VNO
46
-13
PCAR
56
-5
T
48
3
FAST
57
-3
GRMN
67
-4
ORCL
63
-4
D
40
2
GOOG
57
-6
PYPL
52
-2
EXR
57
2
IFF
47
-4
WMB
68
2
ICE
59
-3
ILMN
32
-9
HUM
41
-4
PSA
56
3
RIG
43
-7
REGN
38
-2
MMM
35
-5
KR
36
-6
VNO
46
-13
PCAR
56
-5
T
48
3
FAST
57
-3
GRMN
67
-4
ORCL
63
-4
D
40
2
GOOG
57
-6
PYPL
52
-2
EXR
57
2
IFF
47
-4
WMB
68
2
ICE
59
-3
ILMN
32
-9
HUM
41
-4
PSA
56
3
RIG
43
-7
REGN
38
-2
MMM
35
-5
KR
36
-6
Financhill
Back

Integra Lifesciences Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
36

IART
Integra Lifesciences Holdings

Last Price:
22.51
Seasonality Move:
10.13%
Sell
30

CATX
Perspective Therapeutics

Last Price:
6.98
Seasonality Move:
40.67%
Sell
36
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy, Sell or Hold?

  • The current Integra Lifesciences Holdings [IART] share price is $22.88. The Score for IART is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IART Stock Price Chart

What is Integra Lifesciences Holdings's stock price today?

  • The Integra Lifesciences Holdings share price today is $22.88
    The current trend is moderately bullish and IART is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $7.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

IART Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.35 Buy
Relative Strength Index (14 RSI): 55.61 Buy
Chaikin Money Flow: -727538 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.72 - 24.1) Buy
Bollinger Bands (100): (17.75 - 27.17) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 19.21 Sell
Chaikin Money Flow: -1814221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 12.81) Sell
Bollinger Bands (100): (11.15 - 14.37) Sell

IART Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.59 Sell
20-day SMA: 21.89 Buy
50-day SMA: 19.52 Buy
200-day SMA: 27.91 Sell
8-day EMA: 23.6 Sell
20-day EMA: 22.38 Buy
50-day EMA: 21.28 Buy
200-day EMA: 27.06 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 11.39 Sell
50-day SMA: 12.61 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.13 Sell
50-day EMA: 12.15 Sell
200-day EMA: 11.67 Sell

Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Integra Lifesciences Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):